核酸药物:最近的进展和未来的前景
Xiaoyi Sun1, Sarra Setrerrahmane2, Chencheng Li1
1Jiangsu Province Engineering Research Center of Synthetic Peptide Drug Discovery and Evaluation, China Pharmaceutical University, Nanjing, 210009, China.
核酸药物 (NAD) 提供高效的基因编辑,但面临着交付挑战. 化学修饰和输送策略的进步正在改善它们的稳定性,向性和对各种疾病的临床应用.
科学领域:
- 生物技术是生物技术.
- 药理学 药理学是指药理学的学科.
- 分子生物学分子生物学
背景情况:
- 治疗剂的开发面临着小分子和生物制剂的挑战,特别是对于"无药"的疾病.
- 核酸药物 (NAD) 代表了一代有希望的基因编辑方式,具有高效率和快速发展潜力.
研究的目的:
- 审查核酸药物 (NAD) 的开发,分类和输送策略.
- 突出基因治疗中NADs的临床成功,局限性和未来潜力.
主要方法:
- 关于NADs的发展,化学修饰技术和各种交付方法的文献综述.
- 对临床试验数据和NADs批准的治疗应用的分析.
主要成果:
- 化学修饰增强NADs的物理化学特性,但载体通常需要用于细胞吸收和细胞内向.
- 已经开发出多种输送策略,以改善NADs的体内生物利用性和细胞内输送.
- 几种NAD已经进入临床试验,并获得治疗用途的监管批准.
结论:
- 作为基因疗法候选人,NADs显示出显著的希望,克服了传统治疗方法的局限性.
- 传递系统和化学修饰的持续进步对于扩大NADs的临床应用至关重要.
- NADs正在迅速发展,为治疗各种疾病提供了新的途径.
更多相关视频
09:04Sequence-specific and Selective Recognition of Double-stranded RNAs over Single-stranded RNAs by Chemically Modified Peptide Nucleic Acids
Published on: September 21, 2017
10:29Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
Published on: May 9, 2025
相关概念视频
Microorganisms in Medicine and Therapeutics
Next-generation Sequencing
Next-Generation Sequencing Methods
Although all next-generation methods use different technologies, they all share a set of standard features....
Nucleic Acids and Nucleotides
Deoxyribonucleic Acid (DNA)
DNA is the genetic material in all living organisms, ranging from single-celled bacteria to multicellular mammals. It is in the nucleus of eukaryotes and the organelles such as chloroplasts and mitochondria....
Viruses with RNA Genomes
Drug Discovery: Overview
Principles of Drug Action
Drugs can be agonists or antagonists. Like the endogenous ligands, agonists always bind and activate the target to produce a cellular response. Agonist binding induces a conformational change which in turn...
